255 related articles for article (PubMed ID: 34232706)
1. SUMO paralogue-specific functions revealed through systematic analysis of human knockout cell lines and gene expression data.
Bouchard D; Wang W; Yang WC; He S; Garcia A; Matunis MJ
Mol Biol Cell; 2021 Sep; 32(19):1849-1866. PubMed ID: 34232706
[TBL] [Abstract][Full Text] [Related]
2. Paralogue-Specific Roles of SUMO1 and SUMO2/3 in Protein Quality Control and Associated Diseases.
Wang W; Matunis MJ
Cells; 2023 Dec; 13(1):. PubMed ID: 38201212
[TBL] [Abstract][Full Text] [Related]
3. Insights into high affinity small ubiquitin-like modifier (SUMO) recognition by SUMO-interacting motifs (SIMs) revealed by a combination of NMR and peptide array analysis.
Namanja AT; Li YJ; Su Y; Wong S; Lu J; Colson LT; Wu C; Li SS; Chen Y
J Biol Chem; 2012 Jan; 287(5):3231-40. PubMed ID: 22147707
[TBL] [Abstract][Full Text] [Related]
4. Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3.
Evdokimov E; Sharma P; Lockett SJ; Lualdi M; Kuehn MR
J Cell Sci; 2008 Dec; 121(Pt 24):4106-13. PubMed ID: 19033381
[TBL] [Abstract][Full Text] [Related]
5. Distribution and paralogue specificity of mammalian deSUMOylating enzymes.
Kolli N; Mikolajczyk J; Drag M; Mukhopadhyay D; Moffatt N; Dasso M; Salvesen G; Wilkinson KD
Biochem J; 2010 Sep; 430(2):335-44. PubMed ID: 20590526
[TBL] [Abstract][Full Text] [Related]
6. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
Citro S; Chiocca S
Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
[TBL] [Abstract][Full Text] [Related]
7. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
[TBL] [Abstract][Full Text] [Related]
8. Senp1 is essential for desumoylating Sumo1-modified proteins but dispensable for Sumo2 and Sumo3 deconjugation in the mouse embryo.
Sharma P; Yamada S; Lualdi M; Dasso M; Kuehn MR
Cell Rep; 2013 May; 3(5):1640-50. PubMed ID: 23684609
[TBL] [Abstract][Full Text] [Related]
9. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
[TBL] [Abstract][Full Text] [Related]
10. Small Ubiquitin-like Modifier Alters IFN Response.
Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
[TBL] [Abstract][Full Text] [Related]
11. Human SUMO fusion systems enhance protein expression and solubility.
Wang Z; Li H; Guan W; Ling H; Wang Z; Mu T; Shuler FD; Fang X
Protein Expr Purif; 2010 Oct; 73(2):203-8. PubMed ID: 20457256
[TBL] [Abstract][Full Text] [Related]
12. SUMO2 is essential while SUMO3 is dispensable for mouse embryonic development.
Wang L; Wansleeben C; Zhao S; Miao P; Paschen W; Yang W
EMBO Rep; 2014 Aug; 15(8):878-85. PubMed ID: 24891386
[TBL] [Abstract][Full Text] [Related]
13. Interferon controls SUMO availability via the Lin28 and let-7 axis to impede virus replication.
Sahin U; Ferhi O; Carnec X; Zamborlini A; Peres L; Jollivet F; Vitaliano-Prunier A; de Thé H; Lallemand-Breitenbach V
Nat Commun; 2014 Jun; 5():4187. PubMed ID: 24942926
[TBL] [Abstract][Full Text] [Related]
14. SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML.
Fasci D; Anania VG; Lill JR; Salvesen GS
Sci Signal; 2015 Jun; 8(380):ra56. PubMed ID: 26060329
[TBL] [Abstract][Full Text] [Related]
15. Acetylation of SUMO2 at lysine 11 favors the formation of non-canonical SUMO chains.
Gärtner A; Wagner K; Hölper S; Kunz K; Rodriguez MS; Müller S
EMBO Rep; 2018 Nov; 19(11):. PubMed ID: 30201799
[TBL] [Abstract][Full Text] [Related]
16. Analysis of a degron-containing reporter protein GFP-CL1 reveals a role for SUMO1 in cytosolic protein quality control.
Wang W; Lu J; Yang WC; Spear ED; Michaelis S; Matunis MJ
J Biol Chem; 2023 Feb; 299(2):102851. PubMed ID: 36587767
[TBL] [Abstract][Full Text] [Related]
17. Effect of endosulfan and bisphenol A on the expression of SUMO and UBC9.
Yarahalli Jayaram V; Baggavalli S; Reddy D; Sistla S; Malempati R
Drug Chem Toxicol; 2020 Nov; 43(6):637-644. PubMed ID: 30426790
[TBL] [Abstract][Full Text] [Related]
18. Sumoylation differentially regulates Sp1 to control cell differentiation.
Gong L; Ji WK; Hu XH; Hu WF; Tang XC; Huang ZX; Li L; Liu M; Xiang SH; Wu E; Woodward Z; Liu YZ; Nguyen QD; Li DW
Proc Natl Acad Sci U S A; 2014 Apr; 111(15):5574-9. PubMed ID: 24706897
[TBL] [Abstract][Full Text] [Related]
19. Swapping small ubiquitin-like modifier (SUMO) isoform specificity of SUMO proteases SENP6 and SENP7.
Alegre KO; Reverter D
J Biol Chem; 2011 Oct; 286(41):36142-36151. PubMed ID: 21878624
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone receptor isoform-specific modification by small ubiquitin-like modifier (SUMO) modulates thyroid hormone-dependent gene regulation.
Liu YY; Kogai T; Schultz JJ; Mody K; Brent GA
J Biol Chem; 2012 Oct; 287(43):36499-508. PubMed ID: 22930759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
